ClinicalTrials.Veeva

Menu

Impact of FDG-PET/CT on Management of Patients with Native Valve Infective Endocarditis (PET-NAVIE)

U

University of Montreal

Status

Enrolling

Conditions

Native Valve Endocarditis
Infective Endocarditis

Study type

Observational

Funder types

Other

Identifiers

NCT04792281
MP-33-2020-2674

Details and patient eligibility

About

The proposed study is a multicentric prospective observational cohort study of patients with suspected NVE. The study population includes those with Possible IE according to the modified Duke criteria and investigated at one of the 6 participating sites which include 2 cardiac centers, the MHI and the IUCPQ, as well as 4 tertiary care centers, the Jewish General Hospital , the McGill University Health Centre and the CHUS.

Enrollment

97 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 years of age or older, capable to provide informed consent;
  • Referred for a FDG-PET/CT study
  • Classified as having Possible IE prior to FDG-PET/CT imaging;
  • Patients must be able to tolerate the physical/logistical requirements of a PET/CT scan.

Exclusion criteria

  • Subjects with prosthetic cardiac valve and/or CIED;
  • Pregnant or breastfeeding female;
  • Body mass index > 45 kg/m2.

Trial design

97 participants in 1 patient group

Patients with suspected native valve endocarditis

Trial contacts and locations

6

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems